Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD

Yazar: Lewis, S J, Rodbard, H W, Fox, K M, Grandy, S
Baskı/Yayın Bilgisi 2008

Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomiz...

Yazar: Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Yayımlandı Diabetes Obes Metab (2016)

Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin

Yazar: Rodbard, H. W., Seufert, J., Aggarwal, N., Cao, A., Fung, A., Pfeifer, M., Alba, M.
Yayımlandı Diabetes Obes Metab (2016)

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naïve patients with type 2 diabetes

Yazar: Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Wolden, M L, Rana, A, Mathieu, C
Yayımlandı Diabetes Obes Metab (2014)

Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin‐naïve people with Type 2 diabetes: the DUAL...

Yazar: Rodbard, H. W., Bode, B. W., Harris, S. B., Rose, L., Lehmann, L., Jarlov, H., Thurman, J.
Yayımlandı Diabet Med (2016)

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Yazar: Rodbard, H. W., Buse, J. B., Woo, V., Vilsbøll, T., Langbakke, I. H., Kvist, K., Gough, S. C. L.
Yayımlandı Diabetes Obes Metab (2016)

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial

Yazar: Rodbard, H W, Cariou, B, Zinman, B, Handelsman, Y, Philis-Tsimikas, A, Skjøth, T V, Rana, A, Mathieu, C
Baskı/Yayın Bilgisi 2013

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled tr...

Yazar: Ahmann, A., Rodbard, H. W., Rosenstock, J., Lahtela, J. T., de Loredo, L., Tornøe, K., Boopalan, A., Nauck, M. A.
Yayımlandı Diabetes Obes Metab (2015)

One‐year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26‐week extension to a 26‐week main trial...

Yazar: Gough, S. C. L., Bode, B. W., Woo, V. C., Rodbard, H. W., Linjawi, S., Zacho, M., Reiter, P. D., Buse, J. B.
Yayımlandı Diabetes Obes Metab (2015)

Is adiposopathy (sick fat) an endocrine disease?

Yazar: Bays, H E, González-Campoy, J M, Henry, R R, Bergman, D A, Kitabchi, A E, Schorr, A B, Rodbard, H W
Baskı/Yayın Bilgisi 2008